Study objective: Rapid sequence intubation performed by nonphysicians such as paramedics or nurses has become increasingly common in many countries; however, concerns have been stated in regard to the safe use and appropriateness of rapid sequence intubation when performed by these health care providers. The aim of our study is to compare rapid sequence intubation success and adverse events between nonphysician and physician in the out-of-hospital setting.
INTRODUCTION
Rapid sequence intubation is an advanced airway management process whereby rapidly acting sedative and paralytic drugs are used to aid the placement of an endotracheal tube. The practice of rapid sequence intubation is intended to optimally prepare patients for laryngoscopy and intubation and to facilitate conditions for successful intubation on the first attempt. Out-of-hospital rapid sequence intubation is used by a number of emergency medical services (EMS) in regions such as Australia, 1 Europe, 2 South Africa, 3 and the United States. 4 Previous work involving paramedics in the United States suggested that out-of-hospital rapid sequence intubation may increase mortality in patients with traumatic brain injury. 5 Davis et al 5, 6 theorized that this difference may be related to the low paramedic intubation success rate (84%), multiple severe hypoxic episodes, and frequent hyperventilation, suggesting safety concerns surrounding rapid sequence intubation by nonphysicians. A meta-analysis by Lossius et al 2 found lower success rates for intubation after rapid sequence intubation by nonphysicians compared with physicians (99% versus 96%) and suggested that the out-of-hospital use of intubation should be reconsidered in the absence of a physician.
Editor's Capsule Summary
What is already known on this topic The safety and efficacy of rapid sequence intubation performed by nonphysician providers in the out-ofhospital setting are unclear.
What question this study addressed
A meta-analysis of 83 studies compared intubation success rates and adverse events for physicians and nonphysicians performing out-of-hospital rapid sequence intubation.
What this study adds to our knowledge The authors found a 2% difference in successful intubation (physicians 99%, nonphysicians 97%) and a 10% difference in first-pass rapid sequence intubation success (88% versus 78%). Comparisons for adverse events are hampered by lack of precision, publication bias, and heterogeneity.
How this is relevant to clinical practice
This does not affect practice but provides general knowledge of out-of-hospital performance and identifies ways that data collection could be improved, especially with respect to adverse events.
Other research has also raised concerns in regard to nonphysician rapid sequence intubation and intubation in the out-of-hospital setting. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Dunford et al 17 reported that 57% of their cohort had desaturation events after paramedic rapid sequence intubation, and 48% had recognized esophageal intubations. A South African paramedic rapid sequence intubation program reported a success rate of 100%, but the authors also reported adverse events of up to 22% and raised concerns about the safety of this rapid sequence intubation program. 3 In a meta-analysis of the effect of clinician experience on mortality after intubation, there was a 2-fold increase in the odds of mortality when inexperienced (primarily paramedics) intubated. 18 Peters et al 19 compared intubation by paramedics in helicopter EMS to that of physicians and found first-pass success rate lower when ambulance paramedics were compared with physicians (46.4% versus 84.5%). However, there is some evidence that the success and adverse event profile for nonphysician rapid sequence intubation might not be as poor as these studies suggest. A randomized controlled trial by Bernard et al 1 from Australia found favorable neurologic outcome at 6 months after paramedic rapid sequence intubation compared with inhospital rapid sequence intubation. In contrast to the trial by Davis et al, 5 hyperventilation and hypoxia were uncommon and intubation success rate was considerably higher (97.5%). 1 The trial by Bernard et al 1 suggests that for some nonphysicians, rapid sequence intubation might not be as unsafe as previously suggested and highlights the need for further investigation. Against that background, the aim of this study was to conduct a systematic review that compared rapid sequence intubation success and adverse events between nonphysicians and physicians in the out-of-hospital setting by analyzing success and adverse events.
MATERIALS AND METHODS
This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.
those that appeared in abstract form only, those that reported results from which it was not possible to extract effect size statistics, and those in which it was impossible to assess the methodological quality of the article.
Data Abstraction
Two authors (P.F.F. and P.S.) independently reviewed each included study to identify the following characteristics: study and year, country, paralytic drug, clinician intubating after rapid sequence intubation drugs were administered, type of emergency medical service (ground or flight), overall success proportion, first-pass success, esophageal intubation, cardiac arrest during or after rapid sequence intubation, hyper-or hypotension during or after rapid sequence intubation, hypoxia or desaturation events during or after rapid sequence intubation, emesis during or after rapid sequence intubation, brady-or tachycardia during or after rapid sequence intubation, endobronchial intubations, hypo-or hypercarbia during or after rapid sequence intubation, aspiration during or after rapid sequence intubation, and pneumonia and airway trauma. We extracted estimates only if it was clear from the article that an event happened during or after the rapid sequence intubation procedure. Extraction was piloted for clarity on 5 studies. Disagreements in extracted data were resolved by arbitration and consensus by all authors.
Quality Assessment
We assessed the quality (extent of bias) of each study with a checklist adapted from the prevalence checklist by Hoy et al 22 (Appendix E2, available online at http://www. annemergmed.com). To aid quality ratings, we designed a guide that accompanied the checklist (Appendix E3, available online at http://www.annemergmed.com). Modifications included paraphrasing the wording of each item in the checklist by Hoy et al 22 for the rapid sequence intubation and out-of-hospital checklist. The checklist consisted of 8 items that assessed external and internal validity through 4 domains: selection and nonresponse bias, measurement bias, and bias related to the analysis. 22 Two authors (P.F.F. and C.S.) independently assessed all included studies for quality, and interrater agreement was assessed with an intraclass correlation coefficient. 23, 24 Definitions
We used success and adverse event definitions provided by the authors of the included studies. The adequacy of a particular study definition was formally assessed through the quality rating, and specific standards for definitions are presented in the guidelines for the quality checklist in item 6 (Appendix E3, available online at http://www. annemergmed.com). Physicians were defined as clinicians who had undergone training to qualify them as physicians and included anesthesiologists and emergency physicians. Nonphysicians were defined by exclusion: clinicians able to perform rapid sequence intubation who were not physicians and included paramedics, nurses, firefighter-paramedics, respiratory therapists, and physician assistants.
Primary Data Analysis
The main outcomes were the proportions (expressed as a percentage) of overall success of intubation after rapid sequence intubation drugs, first-pass success, and the various adverse events. When proportions approach 1 (such as with intubation success), the typical equation for a confidence interval (CI) does not prevent CIs' falling outside the range of 0 to 1. 25 Furthermore, when the proportions are very small or large, the variance is pressed toward zero and meta-analysis puts undue weight on studies with extreme proportions. 25 To avoid this pressing effect of the variance and the CI outside the possible range, the double arcsine square-root-transformed prevalence proportion across studies was pooled and results were reported after back-transformation to natural proportions. Although the usual transformation is the logit transformation, the double arcsine square root has been shown to be better at variance stabilization. 25 Meta-analyses were conducted for outcomes that had similar definitions and were therefore considered conceptually a single group. If multiple studies reported data on the same subjects (ie, from the same data set), we selected the least biased study according to the quality assessment to avoid counting data twice. Heterogeneity was determined to be present when the value of s 2 was greater than zero. Both are presented because at higher levels of heterogeneity, for similar I 2 Cochran's Q can still vary considerably. Meta-analyses of heterogeneous studies are often performed with the random-effects model 26 ; however, our analysis was completed with the quality-effects model described by Doi et al 27 and Doi and Thalib. 28 The quality-effects model adjusts for study-level risk of bias and has advantages over the random-effects model, given that the latter model estimate does not allow direct interpretation. 29 Also, the random-effects estimator suffers from faulty error estimation so that CIs generated are too narrow, 30 and the random-effects model also exacerbates estimation of publication bias. 31 Study-level risk of bias was quantified for use in the quality-effects model by averaging the summary quality ratings of each rater (Table) . Funnel plots were not used because they perform poorly when the effect size is a prevalence proportion such as in this analysis 32 ; for this reason, publication bias was examined visually by Doi plots and the Luis Furuya-Kanamori index. 24, 33 The Doi plot uses linear ranking to study asymmetry, in which a symmetric triangle is created with a z score close to zero at its peak if the studies in the analysis are homogenous and not affected by selection or other forms of bias. 24 The Luis Furuya-Kanamori index indicates no asymmetry if within AE1 unit, minor asymmetry if more than AE1 unit but within AE2 units, and major asymmetry if the index exceeds AE2 units. 33 Pooled estimates between physicians and nonphysicians were considered similar if there was an overlap of 95% CIs.
RESULTS
The literature search identified 3,351 articles. After abstract screening and duplicate removal, 89 articles were included in the systematic review, with 83 suitable for meta-analysis ( Figure 1) . A comprehensive listing of the 89 articles undergoing qualitative assessment, including a description of the study characteristics, intubation success rates, and Full-text arƟcles assessed for eligibility (n = 357)
Full-text arƟcles excluded, with reasons (n =268) proportions of adverse effects, is shown in Table E1 , available online at http://www.annemergmed.com.
Characteristics of Study Subjects
Eleven studies were nonrandomized trials, 6,9,34-42 and 2 were randomized controlled trials. 1, 43 Twenty-five were prospective 7, 10, 11, 17, and 51 were retrospective studies. [3] [4] [5] [6] 8, 12, 13, 15, 16, 19, Physicians were the intubating clinicians in 18% of studies, 8, 10, 11, 15, 16, 19 6, 106 The number of individual rapid sequence intubations included in the overall success analysis was 26,353, and 11,349 for the analysis of first-pass success (Table) .
Study Quality
Two raters had moderate agreement, with intraclass correlation coefficient of 0.52 (95% CI 0.20 to 0.74). Study quality was higher for studies that reported physician rapid sequence intubation (mean 6.28 out of a possible 8; 95% CI 5.76 to 5.80) compared with nonphysician rapid sequence intubation (mean 5.43; 95% CI 5.20 to 5.63) and physician or nonphysician rapid sequence intubation (mean 5.20; 95% CI 4.78 to 5.62) (Table) .
Quantitative Synthesis
Overall and first-pass success of intubation after rapid sequence induction. Meta-analysis showed a 2% difference in the overall success between physicians and nonphysicians, 99% (95% CI 98% to 99%) versus 97% (95% CI 95% to 99%) ( Table, Figure 2, Table E3 , available online at http://www.annemergmed.com). There was a 10% lower first-pass success for nonphysicians compared with physicians, 78% (95% CI 65% to 89%) versus 88% (95% CI 83% to 93%) (Table, Figure 2 , Table E4 , available online at http://www.annemergmed. com). However, these estimates lacked precision, as evidenced by overlapping CIs. The Doi plots for the overall and first-pass success meta-analyses were symmetrical (data not shown), and Luis Furuya-Kanamori indices indicated symmetry (Table E2 , available online at http://www. annemergmed.com).
Adverse events. Point estimates for nonphysicians showed 3% less esophageal intubations and hypoxia, 1% more cardiac arrest, 3.7% more endobronchial intubation, 3.5% more bradycardia, 1% more hypertension, 1% more hypotension, and 1% more airway trauma than for physicians (Table, Figure 2 , Tables E5 to E12, available online at http://www.annemergmed.com). No difference in point estimates was observed for emesis or pulmonary aspiration ( Table, Figure 2, Tables E13 and E14 , available online at http://www.annemergmed.com). All estimates except endobronchial intubation lacked precision, and therefore the magnitude and direction of the estimates overlapped for most adverse events. Doi plots and Luis Furuya-Kanamori indices showed gross positive asymmetry in effect sizes for 4 adverse events: esophageal intubation, endobronchial intubation, bradycardia, and hypertension ( Figure E1 and Table E2 , available online at http://www. annemergmed.com). No meta-analysis for tachycardia could be completed because insufficient studies reported purely physician estimates. Furthermore, no meta-analysis for hyperventilation or hypocarbia, or pneumonia, was completed because insufficient studies or unsuitable Figure 2 . Success and adverse events proportions, physicians compared with nonphysicians during or after rapid sequence intubation.
estimates were reported to make a physicians versus no-physicians comparison. Heterogeneity. All analyses showed large heterogeneity except for pulmonary aspiration. Also, there was larger heterogeneity in the overall success proportions of nonphysicians, with I 2 ¼92% compared with physicians I 2 ¼74% (Table) . High heterogeneity was evident for overall success, and also a pattern of higher heterogeneity for nonphysicians was evident across all analyses in which such a comparison was possible.
LIMITATIONS
Our systematic review found large heterogeneity across most analyses, similar to other meta-analyses of advanced airway management. 107, 108 This large heterogeneity warrants caution in interpreting our estimates. There was evidence for possible publication bias for 4 adverse events, raising the likelihood of selective reporting and making their assessments unreliable. Comparisons of the estimates from this analysis with nationwide results such as those from the National Emergency Medical Services Information System (NEMSIS) data provide further evidence for possible selective reporting. As such, the pooled results from this analysis might not be unbiased. Also, painstaking efforts were made to avoid the "unit of analysis" problem, in which some subjects are counted twice because of studies reporting the same subjects across multiple articles. Even so, the data from Tollefsen et al 100 might overlap slightly with the data from NEMSIS reported by Wang et al, 4 but a sensitivity analysis showed that excluding the data from Tollefsen et al 100 did not change the pooled results. Only English-language publications were included in this review, and it is possible that a small number of non-English-language publications exist. Should that be the case, it is unlikely that such studies would alter these estimates and conclusions.
It would have been ideal to meta-analyze clinician types separately, but lack of sufficient data for some clinician types made such analysis unfeasible. Analytic pooling of all nonphysician types probably obscures important differences. Separate analysis could reveal how clinician type causes heterogeneity, which would allow more focused research and training. Finally, the training level of the nonphysician providers (experienced, novice, etc) was not provided. Although experience and level of training affect intubation success, data sets such as NEMSIS do not report provider proficiency with intubation. The interrater agreement beyond chance in this analysis can be considered moderate. A higher agreement would have been ideal, but we believe this moderate agreement does not negate our results. Numerous studies reported adverse events that were unsuitable for metaanalysis. As an example, consider esophageal intubation reports. Twelve studies that were not included in the esophageal intubations analysis reported these events, but in such a way that they were not useful; eg, they reported "no unrecognised esophageal intubations," 34 which did not reveal the actual number of such mishaps. This proved to be a problem with reports of endobronchial intubations too. A lack of adequate reporting and failure to publish these estimates in these instances could explain the asymmetry in the Doi plots ( Figure E1 , available online at http://www.annemergmed.com).
DISCUSSION
This systematic review provides an up-to-date synthesis of nonphysician rapid sequence intubation success and adverse events. Our meta-analysis showed a 2% difference in the overall success in favor of physicians; however, a lack of precision of this estimate suggests that the evidence for these differences might not be reliable. Additionally, a 10% difference in the first-pass success favored physicians. Furthermore, our results showed that for 6 of the 10 adverse events, pooled estimates showed a lower incidence of adverse events for physicians. Nevertheless, for inadvertent esophageal intubation and hypoxia, nonphysician events had more favorable proportions. Large overlap in CIs for 9 of the adverse events makes these differences less than reliable, except for rapid sequence intubation-related endobronchial intubation, which had no overlap. Evidence suggestive of selective reporting or publication for rapid sequence intubation-related bradycardia and hypertension and also for inadvertent endobronchial and esophageal intubation makes the estimates of these adverse events less dependable. Additionally, Doi plots showed gross positive asymmetry for these 4 adverse events, which could mean that lower event rates were underreported for nonphysicians. It follows that none of the differences noted for adverse events could be taken as trustworthy. In most analyses, larger heterogeneity was present among the estimates of nonphysicians, showing that success and adverse events were more variable among nonphysicians, perhaps because of various levels of skill or training.
A 10% difference in first-pass success when physicians are compared with nonphysicians might be a cause for concern. It is best to intubate on the first attempt because repeated attempts at intubation and laryngoscopy have been associated with increased adverse events such as hypoxemia, esophageal intubation, aspiration, and cardiac arrest, and decreased likelihood of return of spontaneous circulation. [109] [110] [111] [112] We consider the first-pass proportion of out-of-hospital physicians the benchmark; nonphysicians should strive to match physician first-pass success. A lack of sufficient or suitable studies precluded a comparison of hyperventilation. Even so, Davis et al 6 reported a 59% rate of hypocarbia (end tidal CO 2 [ETCO 2 ] 25 mm Hg) in their paramedic rapid sequence intubation trial, and rates of 9.5%, 106 as well as 50% (ETCO 2 30 mm Hg), were found in other publications. 48 These high hyperventilation rates contrast with the low paramedic hyperventilation proportions from South Africa (2%). 3 A US ground-based paramedic study reported 10% hyperventilation or hypocarbia. 56 Similarly, we were unable to analyze hypoventilation or hypercarbia because of insufficient studies that reported estimates suitable for analysis. Nevertheless, Bernard et al 66 found a 20% instance of hypoventilation for paramedics (ETCO 2 !45mm Hg), but Gunning et al 3 found a 1% prevalence in a South African rapid sequence intubation program. In a mixed physician and nonphysician crew, Holmes et al 54 reported a 7.6% proportion, whereas Sing et al 93, 94 reported no cases of hypoventilation or hypercarbia for their nurse and paramedic crew. No analyses for pneumonia were completed for similar reasons; however, Davis et al 5 reported 20% pneumonia prevalence in their paramedic-based study. Sing et al 93, 94 demonstrated 17.5% and 21% proportion in the nurse and paramedic configuration, respectively. For a nonphysician and physician crew, Sloane et al 96 reported a 30% prevalence of post-rapid sequence intubation pneumonia. Because we could not analyze hypo-or hyperventilation, pneumonia, and tachycardia, we cannot make a meaningful comparison for these 4 events between physicians and nonphysicians.
We found variations in the definitions used for adverse events for the studies included in this review. For example, the analysis of hypoxia and desaturation revealed at least 7 distinct but related definitions, and this could be a likely source of the heterogeneity observed in the analysis of adverse events. Sollid et al 112 devised a template to solve this lack of uniform reporting by devising standardized definitions for advanced airway management. Future studies should consider reporting their rapid sequence intubation results with that template. To reduce heterogeneity in adverse events and success estimates, uniform data collection and standardized definitions are critical and make comparison of rapid sequence intubation successes and adverse events easier. Another possible cause of heterogeneity was the extent of bias (study quality) of estimates included in this review. Specifically, studies that reported physician success and adverse events were consistently less biased than those from nonphysicians, as the quality ratings show. A strength of our analysis is that it accounted for these study-level biases with the quality effects model.
CONCLUSIONS
This analysis shows that physicians have a higher rapid sequence intubation first-pass and overall success rate, as well as mostly lower adverse event rates for rapid sequence intubation in the out-of-hospital setting. Nevertheless, for all success and adverse events no firm conclusion for a difference can be drawn because of lack of precision of meta-analytic estimates or because of possible selective reporting. First-pass success could be an area in which to focus quality improvement strategies for nonphysicians.
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Impact Factor score, one of many metrics of a journal's influence, is a measure of the frequency with which the average article in a journal has been cited over a given period of time.
Annals' Impact Factor rose to an all-time high this year, to 5.352. Yes (low risk): The defined sampling frame of the study consists of all records of the study period, no data restriction to a subgroup. No (high risk): Data were restricted and the defined sampling frame of the study did not consist of all records, or was not reported sufficiently. 3. Was some form of random selection used to select the sample from the defined sampling frame, or did the researchers endeavor to access all records (a census)? Yes (low risk): A census or random sample was used. No (high risk): The sample was not randomly selected or census was not used; it was selected by handpicking, etc, or was not reported sufficiently. 4. Was the nonresponse bias (nonavailability of data after selection to the sample) less than 20%? After the researcher selected cases for inclusion, did they obtain data from most of the selected subjects? Yes (low risk): The sample had better than or equal to 80% availability of data. No (high risk): The sample was less than 80% of the cases that should have been included, or was not reported sufficiently. 5. Were any reasonable steps taken to ensure accuracy of RSI success or harms/adverse events statistics? Relying on the clinician who conducted the RSI to report success or harms is not always reliable, and separate verification is required. Yes (low risk): !70% statistics were reliable. No (high risk): <70% statistics were unreliable or not reported sufficiently. 6. Were acceptable success/adverse event/harm definitions used when such definitions were required? That is, were the terms and definitions used for success/ adverse event/harm devoid of any ambiguity? Yes (low risk): !70% events had acceptable RSI success/harm definitions, or lacked ambiguity. No (high risk): <70% events had acceptable RSI success/harm definition was not used or was ambiguous. 7. Did the numerator(s) and denominator(s) for the success or harm proportions use the correct sample numbers and therefore match the reported success or harm statistic? If a study reports a success/harm percentage and also reports the fraction/ratio that the percentage is derived from, check that they match. Yes (low risk): !70% numerator(s) and denominator(s) are correct; they match the reported success/harm statistic. No (high risk): <70% numerator(s) and denominator(s) are correct, they do not match the reported success/harm statistic, or statistic is reported without evidence of how it was derived, or not reported sufficiently. 8. Was the mode (eg, health care records, clinician interviews) of data collection the same for all subjects? Yes (low risk): All data were collected in the same way. No (high risk): Some of the data were collected in different ways, or not reported sufficiently. 9. Summary item on the overall risk of study bias.
Count the number of low-risk scores. Sum the number of low-risk scores and add this to item 9. Classify scores into categories: 1, 2, 3¼high risk of bias 4, 5, 6¼moderate risk of bias 7, 8¼low risk of bias RSI, Rapid sequence intubation.
APPENDIX E3 Guidelines for using the rapid sequence intubation checklist
This guideline aims to assist the rater in the interpretation of the checklist and provides examples. To start, some definitions plus examples:
Patient population: This is the population from which the particular emergency service obtains its patients. It might be all potential RSI patients in a specific geographic area (such as a state, province, or city) served by a particular emergency service. Example: An ambulance service such as Ambulance Victoria in Australia serves all potential RSI patients in the state of Victoria, Australia. The patient population is therefore the potential RSI patient over the whole of Victoria.
Sampling frame: The group of patients who were actually treated by the paramedic service during the study period. Example: All patients who received RSI by paramedics for 12 months in Victoria.
Defined sampling frame: After the researchers apply the particular studies' inclusion and exclusion criteria to a sampling frame, they are left with the defined sampling frame. Ideally, the inclusion and exclusion criteria are such that the defined sampling frame resembles the sampling frame closely, but this is often not the case. Example: A study has a defined sampling frame for only pediatric patients who received RSI by paramedics for 12 months in Victoria after excluding adults, who normally undergo RSI.
Sample: The sample is the group of patients extracted by sampling out of the defined sampling frame for inclusion in the study. Example: The inclusion criteria of this Victorian study restrict the sampling frame to trauma only for the 12-month study period. The researchers then randomly sampled from this defined sampling frame, and what is left is the sample.
ITEM 1
This item aims to assess the extent to which the composition of the patient population affects external validity of a study. An externally valid study means that the results of the study can be readily applied to a group of patients typically treated in practice. Item 1 does this by finding out whether the patient the particular service treats is similar to the "wider" population of RSI patients. In the context of RSI in the out-of-hospital field, a typical population is one composed of a mix of trauma and "medical" patients of all ages. Medical patients are those who need RSI because of causes other than trauma; for example, stroke, seizures, and other nontraumatic causes. It might be that the service treats patients who are typical (good medical trauma mix, all ages), but the researchers select only a subset (such as trauma) for their study. In this instance, item 1 will still receive a low-risk-of-bias score because this service treats a "typical" population and the reduction to trauma only for their study will be assessed in another item of this checklist. Therefore, item 1 asks, who does this service typically treat with RSI, and are they comparable to the RSI superpopulation to whom we are going to generalize the systematic review results?
For the purposes of this study, an acceptable patient population is one that includes a mix of trauma and medical and all ages. Any trauma:medical ratio is acceptable. Using the trauma/medical and age criteria, if the patient population has sufficient trauma and medical patients (and treats adults and children), it has a low risk of bias for this item. This item is concerned with the composition of the patient population the emergency service typically treats, not of the sample or the sampling frame. This item assesses only medical:trauma ratio and age mix. There are other aspects that are relevant, but we will focus only on these 2 factors.
Examples Rating and Comments
A flight medical service treats 80% trauma and 20% medical routinely of all ages.
Yes (low risk).
A flight medical service treats only trauma patients. No (high risk). Must include at least some medical patients. A road-based service has a typical patient population of 70% medical and 30% trauma.
Yes (low risk). It is the inverse of the first example, but this is still a good trauma/medical mix. A paramedic service treats patients of all ages, race, and medical/trauma mix. However, their service is to cities and other major metropolitan areas, with no rural patients included.
Yes (low risk). All criteria are met; if service is in a city, this does not affect the mix for our purposes.
A road-based service does not report the composition of their usual patient population. However, their study sample contains 81% trauma and 19% medical of all ages.
Yes (low risk). It can be inferred that the patient population is representative.
A study does not report the nature of their serviced population; no mention of age range, medical or trauma ratio. Nor can these be reasonably inferred from the text.
No (high risk). If they did not report these factors, we must assume that the service does not treat a representative population and that the external validity is possibly poor. If they report only one aspect (say age range) but do not mention the medical:trauma ratio, then this is insufficient too and is a high risk for bias.
ITEM 2
If the records collected by the researchers are not the whole sampling frame by choice of the researchers, ie, only a part of the records from the sampling frame form their reduced cohort because of investigator restrictions, then we have a high risk for bias. For example, a helicopter service treats trauma and medical, but the researchers exclude trauma patients from this sampling frame, resulting in a defined sampling frame without trauma patients. This is an instance of high risk of bias because their research population is only a subset of the actual group of patients treated by that service. Another example: A road-based service might treat all ages, but the authors decide to assess the RSI success proportion of their elderly patients aged greater than or equal to 70 years (which is only one portion of their sampling frame); this is high risk again because of restriction. Data "restriction" can happen without investigator choices; for example, if a subgroup of data is not available for whatever reason (say, data of medical patients lost in a fire). This is assessed by item 4; the focus of item 2 is data restriction by the study investigators.
Examples Rating and Comments
A helicopter service has a typical patient population of trauma and medical, all ages and in a large metro area. Researchers set out to measure RSI adverse events in a subset of stroke patients only.
No (high risk). The sampling frame is restricted to a subgroup (stroke patients) by their inclusion criteria, making the results less useful to this systematic review. A road-based service decides to find out the RSI success rates of all patients they treat for 1 y. The sampling frame is not restricted because they identify all patients who received RSI from health care records.
Yes (low risk). There was no restriction of data they collected from the patient population.
A pediatric road-based service aims to identify instances of hypotension after RSI in their pediatric population. Their sampling frame is all records in their service without restriction. However, they could obtain records for only 68% of the children.
Yes (low risk). There were no subgroups. That they could obtain only 68% of records did not matter for this item; it is assessed in item 4.
An aeromedical RSI success rate study states in its exclusion criteria that it excludes cases with contraindications to suxamethonium and ketamine, which are their usual RSI drugs.
Yes (low risk). Excluding patients with contraindications to RSI drugs is not data restriction because they would not have received RSI anyway.
A study aims to find success rates of emergency physicians in their aeromedical service, although RSI is conducted by anesthesiologists and other specialties that work on their helicopters. They exclude records in which these other specialties conducted the RSI.
No (high risk). Although the aim was to study emergency physicians' success rates, data restriction still took place because the sampling frame includes records for all types of specialties, and they restricted data by their exclusion. The records collected by the researchers are not the whole sampling frame by choice of the researchers, ie, only a part of the records form the sampling frame now once the investigators applied their restrictions. A study does not report how it derived the sampling frame and we do not know whether data restriction exists.
No (high risk).
ITEM 3
The study sample should closely resemble the defined sampling frame. See definitions above. The sampling frame and defined sampling frame are not quite the same. Sampling can be conducted with a census or a random sampling. A census occurs when the researcher aims to collect every health care record/clinical sheet/data item of their defined sampling frame. A random sample is conducted by using a random process to select a representative sample from the defined sampling frame. A random sample should be large enough to achieve a representative sample. Unlike item 2, which determines how data were restricted, this item focuses on whether the study sample was created so that all records of the defined sampling frame had an equal chance of being included.
Examples Rating and Comments
A military paramedic organization aims to find the RSI success rate of their medics on soldiers. They decide to include only male patients who were in combat. They decide to conduct a random sample of this patient population that includes only male patients.
Yes (low risk). Despite the patient population not being typical as assessed in item 1, and regardless of the data restriction to male patients only (assessed by item 2), researchers did conduct a random sample. The scores of items 1 and 2 do not affect this item. A pediatric service aims to find the number of inadvertent esophageal intubations in RSI during a year. Although they had access to all records, they decided to use only the records of RSI by physicians as the defined sampling frame (and they state this in their criteria) and undertook a census of the physician intubations.
Yes (low risk). They conducted a census.
An aeromedical nurse-based service aims to assess the RSI success rate of all patients they treat. They accessed all records during a year and included these in their study.
Yes (low risk). This is an example of a census.
A helicopter service wants to find the RSI bronchial intubation proportion for 1 y. They identify that 23% of the records are printed (not electronic), and they do not obtain these records because of the extra labor it entails.
No (high risk). They did not use a random process or census to select the sample; they handpicked records that are easily obtainable despite all records available.
ITEM 4
If the sample is much smaller because of nonavailability of data (not by investigator choice, as in item 2), then we cannot be sure that the results of the study are true because the nonavailable data might be systematically different from the available data, causing a nonresponse bias. Data should be available for 80% of cases or more that are identified after census or random selection. Stated differently, if the researcher is unable to obtain data from !80% of RSI cases that were selected into the study (eg, through identification numbers), then this poses a significant risk of nonresponse bias. If it is not clear from the study, ie, it cannot be assessed because of lack of information, then this too poses a high risk of bias. This item is different from item 2, which assesses data restriction to a subgroup, which is typically conducted with the inclusion/exclusion criteria. If no information is available to assess nonresponse bias, then we must assume high risk.
Examples Rating and Comments
An RSI success study identified 350 records that met inclusion and exclusion criteria; the researcher could locate only 212 records because the others were lost and incomplete.
No (high risk). Nonresponse is 100-(212/350)¼39%, which is larger than 20%.
A study reports that the sample size is 456 RSI patients, but it does not mention how this sample was selected and whether this was a sample after nonresponse.
No (high risk). We are unable to assess nonresponse bias because the authors did not mention how large the census or random sample was from which the 456 were drawn.
ITEM 5
It is easy to see that a clinician might have reason to be less than truthful about success and harm events when using RSI. For this reason, if the RSI success and harm proportions were self-reported by the clinician or how success or harm was verified is not mentioned, then this presents a risk of bias. For success and harm statistics to be reliable, RSI events needs to be independently verified. We will demonstrate this by using an example of intubation success: intubation is independently verified by radiologic means or confirmation by another clinician by visual inspection of the endotracheal tube's having passed through the vocal cords, or by the use of technology such as ETCO 2 , colorimetric CO 2 bulb/syringe devices, or any other similar technology. By "confirmation by another clinician by visual inspection," it is meant that another clinician visually inspects (with a laryngoscope, for example) the airway after the intubation to verify placement. This commonly happens when a clinician hands over an intubated patient to the emergency department, where the emergency physician confirms placement by inspecting the airway with a laryngoscope or ETCO 2 monitor and auscultation, etc. If the article indicates that another clinician verified endotracheal tube placement, regardless of how that clinician verified, then this is acceptable. But clinician verification is just one acceptable way of confirmation. Intubation success can also be verified independently by other means, such as radiograph (radiologic) or colorimetric CO 2 detectors, or bulb/syringe devices, or any other acceptable technology. You are the judge of "acceptable technology." We will use intubation success as a proxy for RSI success in this systematic review.
These other means (radiologic, ETCO 2 , bulb devices, etc) do not require another clinician double-checking them; for example, a radiograph does not have to be read by 2 clinicians, nor does a bulb/syringe device need double verification. Independent verification is not foolproof, but our aim is to be reasonably sure of the veracity of RSI events. Item 5 deals with verification of success and harms, compared with item 6, which pertains to definitions; do not confuse the 2 items. If the researchers do not mention what steps were taken to ensure that a statistic was reliable, then this has a high risk of bias. For a study to receive a low-risk-of-bias score, !70% of the statistics it reports must be verified by the means described here; if less, then we would consider it to be biased. The accuracy of potentially success and harmful/adverse events is reliable when the following occur: RSI intubation success: If the intubation after the administration of RSI drugs is verified by another clinician, or with radiologic means such as radiograph, magnetic resonance imaging, computed tomography scan, or any of (but not limited to) ETCO 2 , colorimetric CO 2 bulb/syringe devices, or any other similar technology, then it is acceptable. If the success is verified only by the intubating clinician's visualizing the tube pass through the cords, or using auscultation only or just vapors in the endotracheal tube only, etc, then this presents a high risk of bias and the statistics are not reliable. First-pass success: Because the numbers of intubations are typically witnessed by other clinicians on scene, the researchers do not have to define how they confirmed the reliability of first-pass success. Esophageal intubations: Two types are found: the clinician recognizes he or she intubated esophagus and corrects, or esophageal intubation is found on arrival at hospital. Self-report is acceptable, and the report by the receiving clinician inhospital is similarly adequate. Cardiac arrest, hypo/hypertension, hypoxia/desaturation, airway trauma, bradycardia/tachycardia postendobronchial intubation, hypo/hypercarbia, hypo/ hyperventilation, dislodged/misplaced intubation, and aspiration event do not require independent verification because they are either self-evident or not prone to misclassification. Therefore, the steps involved in calculating the rating for item 5 are:
1. Make a list of all the RSI success and harm outcomes reported in the article that are listed in item 5 above. 2. One by one, go through the list and compare each outcome with those in the above paragraph of the guide and check whether the verification in the article is acceptable, using the template above. 3. Tally the number of outcomes that had an acceptable verification method, and calculate the percentage that results from this fraction. For example, if an article reports 8 outcomes but report adequate verification methods for only 5 of them, then item 5 would receive a high-risk score because only 5/8 (z63%) outcomes were verified satisfactorily.
ITEM 6
Item 5 (above) assesses the way an event is verified as true or not, ie, whether the "test" used to verify an event is reliable. But the event itself needs to be well defined. That is, a study needs to report acceptable definitions for most RSI success/harm it reports. It is obvious that the definition used for success and harms events can affect the prevalence of that success or harm. For example, if one study defines hypotension after RSI as a decrease in blood pressure of more than 20%, but the other defines hypotension as a systolic blood pressure of less than 90 mm Hg at any time after RSI, it is easy to see that these 2 studies might have very different proportions of hypotension. Also, combining statistics of success and adverse events into a meta-analysis that have very different definitions (and therefore prevalences) is a significant cause of heterogeneity. The researchers need to define clearly, unambiguously, and using an acceptable definition for at least 70% of the statistics they report in their article.
What is an acceptable definition of success and an adverse event? Sometimes a definition also includes the way the event was verified, so there can be some overlap between items 5 and 6. For example, a researcher states that hypoxia is defined as a pulse oximeter reading less than 90%. Because hypoxia was measure with a pulse oximeter and this is considered independent verification, item 5 is low risk. But in this instance, the definition contains the means of verification required for item 5, plus additional requirements (SpO 2 <90%) that form a definition. Definitions for all success and events should contain the elements in the template below. We will use as a template the suggested definitions by Sollid et al 112 and alter as needed, and define events not found in that article ourselves. The following are the acceptable definitions:
1. First-pass success: Success as defined on first attempt of intubation. This definition is obvious, and authors do not have to define this. 2. RSI success: Intubation success is used as a proxy for RSI success. An RSI is considered successful if intubation after the administration of RSI drugs is successful. An acceptable definition states directly or through implication that the tube should be seated in the trachea. It is also acceptable to define success by defining failure, and success would be the reciprocal. The definition could refer to an anatomic structure; for example, "success is when the tube passed beyond vocal cords and is seated in the trachea," or "esophageal or bronchial intubations not considered successful," or implies that the tube is in the correct position/anatomy, eg, "intubation success was defined as an appropriate waveform on the ETCO 2 ." An example of unacceptable definition is "defined as the tube seated in the correct position" because the researchers did not state or imply what the correct position is. Circular definitions are not acceptable; for example, "RSI success was achieved when the tube was placed successfully." 3. Esophageal intubations: Obvious and does not need to be defined. 4. Cardiac arrest: Obvious and does not need to be defined. 5. Hypertension post-RSI: The authors can use a threshold value of blood pressure or an increase beyond a baseline as part of their definition.
Examples Rating and Comments
A study reports RSI success rates of 98%, but does not mention how the accuracy was confirmed.
No (high risk). No mention of radiologic or other clinician checking for endotracheal tube placement; no mention of ETCO 2 , bulb syringe devices used, etc. They do not tell us why we should believe this 98% statistic. A study reports RSI success rates and the proportion of esophageal intubations that the intubator recognized and corrected. The authors verified the accuracy of the RSI success by saying that intubation was verified by colorimetric ETCO 2 detector.
Yes (low risk). An acceptable means of verifying tube placement (ETCO 2 ) was used and self-report of esophageal intubation is acceptable.
An RSI study from an aeromedical service reports in their methods section RSI success, instances of hypotension after RSI, airway trauma, number of cardiac arrest post-RSI, and bradycardia. They explain how they verified intubation success by using a bulb/syringe device, and cardiac arrest is verified by printouts of code reports from the defibrillator machine. But they do not state how they verified accuracy of hypotension, and they state bradycardia was confirmed by counting of a pulse by one clinician.
Yes (low risk). This article reports 5 outcomes; RSI/intubation success is verified with acceptable means. And the rest do not require verification (5/5¼100).
A study reports RSI success and first-pass success in the results section without having mentioned them in the methods; no mention how they verified the truth of these statistics.
No (high risk). All the outcomes failed to mention how they were verified.
ITEM 7
Proportions are often reported for multiple successes and harms, and they have to match. For example, if a study reports a 98% intubation success rate after RSI, and you look at the number from which they derived this statistic, they should be equivalent. Often this supporting information is located in a table or as free text in the results section. Seventy percent or more of outcomes listed in the methods section should have verifiable statistics; all statistics and the fractions from which they are derived should match. If a study presents statistics from outcomes mentioned in the methods section with supporting fractions for !70%, then one would consider that a low risk of bias. It is rather tedious to double-check the articles' calculations, but be thorough. You do not have to check the proportions and statistics for outcomes that are not listed in items 5 and 6. Often articles report outcomes and statistics that are not relevant to this systematic review; we are not concerned with the veracity of these statistics.
Examples
Rating and Comments
An RSI study of paramedics in a helicopter service reports a 92% RSI success rate, and in Table 1 we find the numerator and denominator that were used to derive this 92% figure. The fraction from the table is 312/ 395.
No (high risk). 312/395¼79%, not 92%; they miscalculated.
A methods section indicates and the results section reports multiple outcomes: success, hypoxia, cardiac arrest, endobronchial intubation, and hyperventilation. In Table 2 we find numerators and denominators for most of these events, except for hyperventilation.
Yes (low risk). Numerators and denominators for !70% statistics must be presented in the article that is planned for in the methods. The failure to report the fraction for one is not a problem because 4/5¼80%.
A study reports a 97% success rate for RSI, but nowhere in the article can we find the numerators and denominators from which this statistic is derived.
No (high risk). How do we know the authors calculated this statistic reliably? We do not, so this has a high risk.
A study presents 7 outcomes, and presents in a table the numerators and denominators for all these outcomes.
Yes (low risk). We have all the information to double-check their calculations.
A study describes 8 outcomes in the methods, but reports 12 in the results. Of the outcomes reported only in the results, but not described in the methods, 2 do not match.
Yes (low risk). We focus only on the outcomes described in the methods and their results. The extras do not matter, whether they have errors or not.
The methods section mentions outcomes: intubation success, hypotension, the patient's weight, Mallampati view, and size of tube. They report correct proportions for all except Mallampati view.
Only success and hypotension are of interest to us because these are the only outcomes mentioned in items 5 and 6. Both have correct portions and statistics; it does not matter that the Mallampati view is faulty because we are not going to use it in our review. The score for item 7 is 2/ 2¼100%.
ITEM 8
Some methods of data collection are more reliable than others. A study should use uniform methods of collection all of its data. If it used more than one method, then one part of the study has data that are less reliable than the other. If the authors do not provide any information on how data were collected, a high risk of bias results.
ITEM 9
See quality checklist for explanation on how to calculate summary score.
Examples Rating and Comments
A study collects 60% of its data from health care records and the other 40% from a mix of video footage and printouts from machines plus postevent debriefing and documentation.
No (high risk). Multiple methods of data collection were used.
A study collects 98% of its data from electronic health care records and the other 2% from handwritten records.
No (high risk). Multiple methods of data collection were used. Although only for a small proportion, it is still a problem for the purposes of this review. A study does not stipulate how data were collected.
No (high risk). We cannot assume that data collection was uniform.
